Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Experimental Cell Research
|
October 15, 2011
Interaction of nucleosome assembly proteins abolishes nuclear localization of DGKζ by attenuating its association with importins
Masashi Okada, Yasukazu Hozumi, Tohru Ichimura, et al.
Journal of Cell Science
|
September 24, 2005
Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity
Jun Sung Lee, Jong Hyun Kim, Il Ho Jang, et al.
The Journal of Biological Chemistry
|
March 21, 2003
The direct interaction of phospholipase C-gamma 1 with phospholipase D2 is important for epidermal growth factor signaling
Il Ho Jang, Sukmook Lee, Jong Bae Park, et al.
Plos One
|
August 1, 2012
A conserved non-reproductive GnRH system in chordates
Takehiro G Kusakabe, Tsubasa Sakai, Masato Aoyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2021
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Journal of Medical Virology
|
October 12, 2022
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, et al.
Scientific Reports
|
August 5, 2020
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
Shun Kaneko, Masayuki Kurosaki, Kouji Joko, et al.
Journal of Gastroenterology
|
April 8, 2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
Keiji Tsuji, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology Communications
|
October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Experimental Cell Research
|
October 15, 2011
Interaction of nucleosome assembly proteins abolishes nuclear localization of DGKζ by attenuating its association with importins
Masashi Okada, Yasukazu Hozumi, Tohru Ichimura, et al.
Journal of Cell Science
|
September 24, 2005
Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity
Jun Sung Lee, Jong Hyun Kim, Il Ho Jang, et al.
The Journal of Biological Chemistry
|
March 21, 2003
The direct interaction of phospholipase C-gamma 1 with phospholipase D2 is important for epidermal growth factor signaling
Il Ho Jang, Sukmook Lee, Jong Bae Park, et al.
Plos One
|
August 1, 2012
A conserved non-reproductive GnRH system in chordates
Takehiro G Kusakabe, Tsubasa Sakai, Masato Aoyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2021
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Journal of Medical Virology
|
October 12, 2022
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, et al.
Scientific Reports
|
August 5, 2020
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
Shun Kaneko, Masayuki Kurosaki, Kouji Joko, et al.
Journal of Gastroenterology
|
April 8, 2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
Keiji Tsuji, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology Communications
|
October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Page
of 7